These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15850669)

  • 1. Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia-neuron interactions.
    Marchetti B; Serra PA; Tirolo C; L'episcopo F; Caniglia S; Gennuso F; Testa N; Miele E; Desole S; Barden N; Morale MC
    Brain Res Brain Res Rev; 2005 Apr; 48(2):302-21. PubMed ID: 15850669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide.
    Morale MC; Serra PA; Delogu MR; Migheli R; Rocchitta G; Tirolo C; Caniglia S; Testa N; L'Episcopo F; Gennuso F; Scoto GM; Barden N; Miele E; Desole MS; Marchetti B
    FASEB J; 2004 Jan; 18(1):164-6. PubMed ID: 14630699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway.
    Marchetti B; Serra PA; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Cioni S; Gennuso F; Rocchitta G; Desole MS; Mazzarino MC; Miele E; Morale MC
    Ann N Y Acad Sci; 2005 Dec; 1057():296-318. PubMed ID: 16399902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.
    Morale MC; Serra PA; L'episcopo F; Tirolo C; Caniglia S; Testa N; Gennuso F; Giaquinta G; Rocchitta G; Desole MS; Miele E; Marchetti B
    Neuroscience; 2006; 138(3):869-78. PubMed ID: 16337092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.
    Tian YY; An LJ; Jiang L; Duan YL; Chen J; Jiang B
    Life Sci; 2006 Dec; 80(3):193-9. PubMed ID: 17049947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide and reactive oxygen species in Parkinson's disease.
    Tieu K; Ischiropoulos H; Przedborski S
    IUBMB Life; 2003 Jun; 55(6):329-35. PubMed ID: 12938735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication.
    Tripanichkul W; Sripanichkulchai K; Finkelstein DI
    Brain Res; 2006 Apr; 1084(1):28-37. PubMed ID: 16564034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.
    Iravani MM; Leung CC; Sadeghian M; Haddon CO; Rose S; Jenner P
    Eur J Neurosci; 2005 Jul; 22(2):317-30. PubMed ID: 16045485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
    Sriram K; Miller DB; O'Callaghan JP
    J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
    Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T
    Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease.
    Przedborski S; Vila M
    Ann N Y Acad Sci; 2003 Jun; 991():189-98. PubMed ID: 12846987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Andrographolide reduces inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuron-glia cultures by inhibiting microglial activation.
    Wang T; Liu B; Zhang W; Wilson B; Hong JS
    J Pharmacol Exp Ther; 2004 Mar; 308(3):975-83. PubMed ID: 14718612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.
    Mena MA; García de Yébenes J
    Neuroscientist; 2008 Dec; 14(6):544-60. PubMed ID: 19029058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse regulation of inducible nitric oxide synthase (iNOS) and arginase I by the protein tyrosine phosphatase SHP-1 in CNS glia.
    Bonaparte KL; Hudson CA; Wu C; Massa PT
    Glia; 2006 Jun; 53(8):827-35. PubMed ID: 16565987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells.
    Wang J; Duhart HM; Xu Z; Patterson TA; Newport GD; Ali SF
    Neurochem Int; 2008 May; 52(6):1037-43. PubMed ID: 18069091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of dopaminergic neurons by the induction of inducible nitric oxide synthase and cyclooxygenase-2 via CD 40: relevance to Parkinson's disease.
    Okuno T; Nakatsuji Y; Kumanogoh A; Moriya M; Ichinose H; Sumi H; Fujimura H; Kikutani H; Sakoda S
    J Neurosci Res; 2005 Sep; 81(6):874-82. PubMed ID: 16041799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain-dependent susceptibility to MPTP and MPP(+)-induced parkinsonism is determined by glia.
    Smeyne M; Goloubeva O; Smeyne RJ
    Glia; 2001 Apr; 34(2):73-80. PubMed ID: 11307156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease.
    Gao HM; Liu B; Zhang W; Hong JS
    FASEB J; 2003 Oct; 17(13):1957-9. PubMed ID: 12923073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treadmill exercise ameliorates dopaminergic neuronal loss through suppressing microglial activation in Parkinson's disease mice.
    Sung YH; Kim SC; Hong HP; Park CY; Shin MS; Kim CJ; Seo JH; Kim DY; Kim DJ; Cho HJ
    Life Sci; 2012 Dec; 91(25-26):1309-16. PubMed ID: 23069581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY; Park HJ; Ahn YH; Lee PH
    J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.